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ABSTRACT 
Background: Interleukin-6 (IL-6) has been known associated with oxidative stress and endothelial dysfunction, and also has important roles in pathogenesis 
of preeclampsia. Several studies have demonstrated that there was a significant increase of serum IL-6 levels in preeclampsia compared to normotensive 
pregnant women. However, study to evaluate serum IL-6 level in pregnant women with HELLP (hemolysis, elevated liver enzyme, and low platelet) 
syndrome is not well documented yet. Objective: This study aims to evaluate serum IL-6 levels between women with HELLP syndrome compared to 
normotensive pregnant. 
Methods: The research design is observational cross-sectional study. Samples were recruited consecutively using inclusion and exclusion criteria from 
emergency department and inpatient wards at Dr. Sardjito General Hospital, Yogyakarta, Indonesia. Serum IL-6 were collected from venous blood 
sample and measured by enzyme-linked immunoassay (ELISA) method. Independent-samples t-test or Mann-Whitney test was used to compare serum 
IL-6 values between women with HELLP syndrome and normotensive pregnancy. A statistical measurement conducted using SPSS IBM Statistics 19® 
and considered significant when p<0,05.
Results: There were 46 subjects, consisted of 23 women with HELLP syndrome and 23 women with normotensive pregnancy. Serum IL-6 level was a 
mean of 0,11±0,08 pg/mL and 0,15±0,20 pg/mL in women with HELLP syndrome compared to normotensive pregnancy respectively. There was no 
significant statistical difference between both groups (p=0,17). 
Conclusion:.The result of this study has shown that there is no significant difference of serum IL-6 level in HELLP syndrome women compared to 
normotensive pregnant women.
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ABSTRAK 
Latar Belakang: Interleukin-6 (IL-6) telah diketahui berhubungan dengan stres oksidatif, disfungsi endotel, dan memiliki peranan dalam 
pathogenesis preeclampsia. Beberapa penelitian sebelumnya membuktikan bahwa terjadi peningkatan kadar IL-6 serum yang signifikan 
pada wanita preeclampsia dibandingkan dengan wanita hamil normotensif. Namun, hingga saat ini penelitian untuk mengetahui kadar 
IL-6 serum pada wanita dengan sindroma HELLP (hemolysis, elevated liver enzyme, and low platelet) belum banyak dilakukan. Tujuan: 
untuk mengetahui kadar IL-6 serum pada wanita dengan sindroma HELLP dibandingkan wanita hamil normotensive.
Metode: Desain penelitian yang digunakan adalah studi observasional potong lintang. Subyek penelitian direkrut dengan metode 
consecutive sampling yang memenuhi kriteria inklusi dan eksklusi dari instalasi gawat darurat (IGD) dan bangsal rawat inap di RSUP 
Dr. Sardjito, Yogyakarta, Indonesia. Pengukuran kadar IL-6 serum dilakukan dengan pengambilan darah sampel vena diikuti dengan 
pemeriksaan metode enzyme-linked immunosorbent assay (ELISA). Perbandingan hasil rerata kadar IL-6 serum pada kedua kelompok 
diuji menggunakan independent-samples t-test atau Mann-Whitney test dengan SPSS IBM Statistics 19®. Hasil dianggap signifikan 
apabila p<0.05.  
Hasil: Didapatkan sebanyak 46 subyek penelitian yang terdiri dari 23 wanita hamil dengan sindroma HELLP dan 23 wanita hamil 
normotensif. Pada penelitian ini tidak ditemukan adanya perbedaan rerata kadar IL-6 serum yang signifikan (mean±SD) pada kelompok 
dengan sindroma HELLP (0,11±0,08 pg/mL) dibandingkan kelompok control (0,15±0,20 pg/mL) (p=0,17). 
Kesimpulan: Hasil dari penelitian ini menunjukkan tidak adanya perbedaan yang signifikan antara kadar IL-6 wanita hamil dengan 
sindroma HELLP dibandingkan wanita hamil normotensif.
Kata Kunci: Interleukin-6, HELLP syndrome, Preeklamsia, normotensif, gangguan hipertensif 
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of  the pathogenesis of  preeclampsia. One of  the 
most important cytokine that plays significant roles 
in the pathogenesis of  preeclampsia is interleukin-
INTRODUCTION
Endothelial dysfunction and increasing 
endothelial permeability are the key characteristics 
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6 (IL-6) (Lockwood et al., 2008). Interleukin-6 may 
significantly increase endothelial permeability by 
changing the endothelial cells shape and altering 
intracellular actin fibers (Didion, 2017). Interleukin-
6 can also reduce prostacyclin synthesis by inhibiting 
the cyclooxygenase enzyme. This can increase the 
thromboxane A2 to prostacyclin ratio, an abnormality 
that commonly occurs in preeclampsia (Lewis et al., 
2010; Lubrano et al., 2008). IL-6 also stimulates 
placenta-derived growth factor (PlGF), which also 
induces systemic vascular dysfunction as a central 
underlying pathogenesis of  preeclampsia (Goulopoulou 
and Davidge, 2015). Oxygen free radicals which were 
abundant during preeclampsia can induce synthesis 
of  IL-6 by endothelial cells. Oxygen free radicals are 
implicated in the pathogenesis of  preeclampsia, because 
it can cause endothelial injury, which later leads to 
reduction in nitric oxide synthesis and prostaglandin 
balance (Aouache et al., 2018).
Concentrations of  serum IL-6 were significantly 
higher (p<0.001) in preeclamptic women (median 7,9 
pg/mL) compared to normal pregnant patients (0, 6 
pg/mL) (Kalinderis et al., 2011). The increasing levels 
of  serum IL-6 in preeclamptic women also has been 
demonstrated by several studies (Molvarec et al., 2011; 
Xie et al., 2011) Another study also found that serum 
IL-6 levels were significantly higher in preeclamptic 
women (median [minimum-maximum] 15,5 [12.0-32.0] 
pg/mL) compared to normotensive pregnant women 
(7,0 [5.0-9.0] pg/mL) and normotensive non-pregnant 
women (6,0 [5.0-8.0] pg/mL) (p<0,001) (Szarka et 
al., 2010).
However, study to evaluate serum IL-6 level in 
pregnant women with HELLP (hemolysis, elevated 
liver enzyme, and low platelet) syndrome is not well 
documented yet. This study aimed to evaluate serum 
IL-6 levels between women with HELLP syndrome 
compared to normotensive pregnant.
METHODS
The research design was observational cross-
sectional study. Forty six samples were recruited 
consecutively using inclusion and exclusion criteria 
from emergency department and inpatient wards at 
Dr. Sardjito General Hospital, Yogyakarta, Indonesia. 
Samples were assigned into two groups, HELLP group 
and normotensive group, 23 subjects of  each. Inclusion 
criteria were (a) HELLP syndrome or normotensive 
pregnant women with gestational age ≥ 32 weeks, (b) 
subjects voluntarily confirmed to participate in the 
study and having been informed of  the full details 
of  study protocols and the implications that might 
be happen during study. Exclusion criteria were (a) 
maternal systemic disorders, (b) premature rupture of  
the membrane, (c) in labor state. The study protocols 
have been approved by Medical and Health Research 
Ethics Committee (MHREC) Faculty of  Medicine, 
Public Health, and Nursing, Universitas Gadjah Mada 
– Dr. Sardjito General Hospital.
Interleukin-6 Measurement 
Serum IL-6 were collected from venous blood 
sample, stored in -80oC refrigerator, and measured 
by enzyme-linked immunoassay (ELISA) method 
(Quantikine ELISA, Human IL-6 Immunoassay D6050, 
R&D Systems, Inc, USA)
Management and treatment for the patients
Management and treatment for the patients or 
subjects were according to standard operating procedure 
which available in Dr. Sardjito General Hospital and did 
not affected by the study protocols. Independent-samples 
t-test were used to compare serum IL-6 values between 
women with HELLP syndrome and normotensive 
pregrnancy. A statistical measurement conducted using 
SPSS IBM Statistics 19® and considered significant 
when p<0,05.
RESULTS 
Baseline characteristics of study population
Baseline characteristics of  subjects which 
participated in this study are illustrated in Table 1. There 
were significant differences in the average gestational 
age at diagnosis between HELLP syndrome women 
and normotensive pregnant women 38,0±1.7 weeks vs. 
39,7±1,3 weeks respectively (p<0,001). There were also 
Table 1. Baseline comparisons for HELLP syndrome group to normotensive group.
Variable HELLP 
syndrome
(n = 23)
Mean±SD
Normotensive
(n = 23)
Mean±SD
T test p
Age (years) 32.08 ± 7.1 29.2 ± 5.3 1.61 0.11
Gestational age (weeks) 38.0 ± 1.7 39.7 ± 1.3 -3.95 <0.001
Body Mass Index 25.5 ± 3.5 24.8 ± 5.3 0.55 0.60
Leukocyte (105/mm3) 13.4 ± 5.8 9.9 ± 2.1 2.80 0.01
Variable
HELLP Synd-G Normotensive-G
Mean±SD
IL-6
0.11 ± 0.08 0.15 ± 0.2
0
0,05
0,1
0,15
0,2
HELLP-G Normotensive-G
L
ev
el
 o
f 
IL
-6
 (
p
g
/m
L
) P > 0.17
Table 1. Baseline comparisons for HELLP syndrome group to normotensive group.
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significant differences in white blood cell (WBC) count 
between HELLP syndrome group and normotensive 
group 13,4±5,8 vs. 9,9±2,1 (p=0,01). This data means 
that baseline characteristic of  women in this study were 
not homogenous. 
The levels of IL-6 in serum were not significantly 
increased in women with preeclampsia
There was no significant difference between 
pro-inflammatory circulating IL-6 in women with 
preeclampsia compared to healthy pregnant women. 
Independent-samples T-test was conducted to analysis 
the mean difference of  serum IL-6 levels between each 
group. Mean serum IL-6 levels was not significantly 
different in HELLP syndrome group (0,11±0,08 pg/
mL) compared to that of  normotensive pregnant 
patients (0,15±0,20),  p-value=0,17 as shown in Table 
2 and Figure 1.
DISCUSSION
Preeclampsia has been thought to be a state 
of  inappropriate increased inflammatory response to 
increased secretion of inflammatory cytokines (Aouache 
et al., 2018). Several literatures and guidelines defined 
preeclampsia as maternal hypertension (>140/90 
mmHg systolic/diastolic blood pressure) and proteinuria 
(>300mg/24 h) (ACOG, 2013; Butalia et al., 2018; 
Williams et al., 2018). In severe preeclampsia-spectrum 
of  disease, it might occurs several comorbidities such 
as hemolysis, elevated liver enzymes, and low platelet 
count (HELLP syndrome) in maternal (Abildgaard 
and Heimdal, 2013).
Although what triggers, etiology, and exact 
mechanisms underlying preeclampsia are still 
incompletely understood, the roles of  cytokines 
including pro-inflammatory cytokines appear to 
be significant key players in maternal systemic 
inflammatory response. Significant body of  evidences 
have reported the increased levels of  circulating serum 
IL-6 levels in women with preeclampsia regardless 
its severity (Kalinderis et al., 2011; Ozler et al., 2012; 
Xiao et al., 2012).
A recent review highlighted the potential roles of  
IL-6 in the pathophysiology of  preeclampsia (LaMarca 
et al., 2011). It was thought that IL-6 together with 
other pro-inflammatory cytokines including tumor 
necrosis factor-α (TNF-α) stimulated T-helper 1 and 
B-lymphocyte activation, that further leads to the 
increased secretion of  endothelin-1, oxidative stress, and 
sFlt-1, which finally contributing to the development of  
hypertension in preeclampsia (LaMarca et al., 2011). IL-
6 can be secreted by several types of  white blood cells 
(WBC) such as monocyte, lymphocyte, macrophage, 
granulocyte, and mast cells. Serum IL-6 levels increased 
linearly with total WBC count (Suzuki et al., 2009).
In this study, authors tried to measure circulating 
levels of  IL-6 in pregnant women with HELLP 
syndrome and normotensive pregnant women as 
controls. According to our findings, in the baseline 
characteristics comparison between both groups showed 
that there was not homogenously distributed. It was 
probably due to two important limitations of  this study. 
First, in our sample recruitment we used consecutive 
sampling method rather than purposive sampling 
(matched-pairs sampling). Second, since our location 
of  study was in the tertiary hospital which was the 
highest referral hospital in Yogyakarta Special Province, 
it made researchers difficult to conduct matched-pairs 
sampling particularly to find normotensive pregnant 
women without any compelling co morbidities. 
In this study, our data showed that there were 
no significant differences of  circulating serum IL-6 
levels in women with HELLP syndrome compared 
to healthy normotensive pregnant women. The result 
of  our study did not support several previous studies 
which measured circulating serum IL-6 levels during 
preeclampsia (Kalinderis et al., 2011; Ozler et al., 2012; 
Xiao et al., 2012) including a meta-analysis conducted 
Table 1. Baseline comparisons for HELLP syndrome group to normotensive group.
Variable HELLP 
syndrome
(n = 23)
Mean±SD
Normotensive
(n = 23)
Mean±SD
T test p
Age (years) 32.08 ± 7.1 29.2 ± 5.3 1.61 0.11
Gestational age (weeks) 38.0 ± 1.7 39.7 ± 1.3 -3.95 <0.001
Body Mass Index 25.5 ± 3.5 24.8 ± 5.3 0.55 0.60
Leukocyte (105/mm3) 13.4 ± 5.8 9.9 ± 2.1 2.80 0.01
Variable
HELLP Synd-G Normotensive-G
Mean±SD
IL-6
0.11 ± 0.08 0.15 ± 0.2
0
0,05
0,1
0,15
0,2
HELLP-G Normotensive-G
L
ev
el
 o
f 
IL
-6
 (
p
g
/m
L
) P > 0.17
Figure 1.  Independent T test on IL-6 Concentration 
betwen Two groups.
Table 2.  Mean serum IL-6 levels difference between 
HELLP syndrome group and Normotensive 
group
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by Xie et al., (2011). In particular, for example, a study 
conducted by Xiao and colleagues (2012) showed 
that there were significantly higher levels of  pro-
inflammatory cytokines IL-6 levels in women with 
preeclampsia and the highest result was in the group 
of  severe preeclampsia. The similar result also has been 
supported by Kalinderis et al., 2011. However, both 
studies only mentioned severe preeclampsia and did 
not mention HELLP syndrome in particular.
According to our best knowledge, the only 
study which measured IL-6 in HELLP syndrome was 
conducted by Ozler et al., (2012). Ozler and colleagues 
did not found any significant differences of  mean 
circulating serum IL-6 levels among mild, severe 
preeclampsia, and HELLP syndrome in compared to 
normal healthy pregnant women group.  
CONCLUSION
There was no significant difference in 
concentration of  IL-6 levels in HELLP syndrome 
women compared to normal pregnant women. It is 
might be caused by the baseline characteristics of  
samples in this study which were not homogenously 
distributed.
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